Detect Disease Sooner, Save Lives Faster
Pioneering breakthroughs in early, non-invasive diagnostics
Detect Disease Sooner, Save Lives Faster
Pioneering breakthroughs in early, non-invasive diagnostics
Our Science
Early detection of cancer remains the most effective solution to eradicate this disease and to prevent subsequent recurrence. By harnessing the biological richness of circulating extracellular vesicles, we can now detect circulating tumor biomarkers early and in turn improve detection of human diseases with emphasis on cancer.
By regularly evaluating individuals, we are developing a novel and non-invasive method of surveillance.
Our Team
Sandra Elliott, MBA
Sandra Elliott, MBA
Sandra Elliott, MBA
President
Olivier Loudig, PhD
Sandra Elliott, MBA
Sandra Elliott, MBA
Scientific Founder
Megan Mitchell, PhD
Sandra Elliott, MBA
Megan Mitchell, PhD
Senior Scientist
Beny Shapiro, PhD
Sandra Elliott, MBA
Megan Mitchell, PhD
Research Scientist
Recent News
Hackensack Meridian Health Research Institute Creates First Spin-Off Company, EValuate Diagnostics
Hackensack Meridian Health Research Institute Creates First Spin-Off Company, EValuate Diagnostics
Hackensack Meridian Health Research Institute Creates First Spin-Off Company, EValuate Diagnostics
EValuate Diagnostics raises $1MM from Foundation Venture Capital Group
Hackensack Meridian Health Research Institute Creates First Spin-Off Company, EValuate Diagnostics
Hackensack Meridian Health Research Institute Creates First Spin-Off Company, EValuate Diagnostics
EValuate Diagnostics Completes NSF Regional I-Corps Hub (Northeast)
Hackensack Meridian Health Research Institute Creates First Spin-Off Company, EValuate Diagnostics
EValuate Diagnostics Completes NSF Regional I-Corps Hub (Northeast)
